Hydroxocobalamin Injection
Brand names: Cyanokit, Hydroxocobalamin
Category: Other
FDA status: Current · Last FDA update: Sep 15, 2026 · First posted: Nov 4, 2024 (in shortage 1 year 10 months) · 2 manufacturers, 2 listed presentations
As of Sep 15, 2026, the FDA lists Hydroxocobalamin Injection as currently in shortage. Of 2 manufacturer presentations, 1 Unavailable, 1 Limited.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) NDC 50633-310-11 |
BTG International Inc. | Limited | Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage. |
| Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30) NDC 0591-2888-30 |
Teva Pharmaceuticals USA, Inc. | Unavailable | Estimated recovery: TBD |
Related medications in shortage
Other Other medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Hydroxocobalamin Injection (FDA data as of Sep 15, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Hydroxocobalamin Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/hydroxocobalamin-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).